Clinical Trial: A clinical study evaluating the efficacy and safety of Gecacitinib Hydrochloride based combination regimen in the treatment of hemophagocytic syndrome (China)

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A clinical study evaluating the efficacy and safety of Gecacitinib Hydrochloride based combination regimen in the treatment of hemophagocytic syndrome'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131759

Registration Time: 2026/09/06

Type: Interventional study

Primary Sponsor: Xi'an Jiaotong University Second Affiliated Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339013

Published by HT Digital Content Services with permission from Health Daily Digest....